The expression of MUC mucin in cholangiocarcinoma

Pathology Research and Practice

Volumn 206, Issue 12, 2010, Pages 805-809

  Mall, Anwar S ^a   Tyler, Marilyn G ^a   Ho, Sam B ^b   Krige, Jake E J ^a   Kahn, Delawir ^a   Spearman, Wendy ^a   Myer, Landon ^a   Govender, Dhirendra ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Cholangiocarcinoma; Immunohistochemistry; Mucin

Indexed keywords

MUCIN 1; MUCIN 2; MUCIN 3; MUCIN 4; MUCIN 5AC; MUCIN 6;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GLYCOSYLATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LIVER CIRRHOSIS; MALE; METASTASIS; OBSTRUCTIVE JAUNDICE; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; TUMOR DIFFERENTIATION; TUMOR LOCALIZATION;

ADULT; AGED; AGED, 80 AND OVER; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; FEMALE; HUMANS; IMMUNOHISTOCHEMISTRY; MALE; MIDDLE AGED; MUCIN 5AC; MUCIN-1; MUCIN-2; MUCIN-3; MUCIN-4; MUCIN-6; MUCINS; TUMOR MARKERS, BIOLOGICAL; YOUNG ADULT;

EID: 78649751257     PISSN: 03440338     EISSN: 16180631     Source Type: Journal    
DOI: 10.1016/j.prp.2010.08.004     Document Type: Article

References (27)

1. Allen A. Structure and function of gastric mucus. Physiology of the Gastro-intestinal Tract 1981, 617-639. Raven Press, New York. L.R. Johnson (Ed.).
2. Rose M.C., Voynow J.A. Respiratory tract mucin genes and mucin glycoproteins in health and disease. Physiol. Rev. 2006, 86:245-278.
3. Hollingsworth M.A., Swanson B.J. Mucins in cancer: protection and control of the cell surface. Nat. Rev. Cancer 2004, 4:45-60.
4. Singh A.P., Chaturvedi P., Batra S.K. Emerging roles of MUC4 in cancer: a novel target for diagnosis and therapy. Cancer Res. 2007, 67:433-436.
5. Porchet N., Dufosse J., Audie J.P., Duperat V.G., Perini J.M., Nguyen V.C., Degand P., Aubert J.P. Structural features of the core proteins of human airway mucins ascertained by cDNA cloning. Am. Rev. Respir. Dis. 1991, 144:S15-S18.
6. Ho S.B., Niehans G.A., Lyftogt C., Yan P.S., Cherwitz D.L., Gum E.T., Dahiya R., Kim Y.S. Heterogeneity of mucin gene expression in normal and neoplastic tissues. Cancer Res. 1993, 53:641-651.
7. Xing P.X., Prenzoska J., Layton G.T., Devine P.L., McKenzie I.F. Second-generation monoclonal antibodies to intestinal MUC2 peptide reactive with colon cancer. J. Natl. Cancer Inst. 1992, 84:699-703.
8. Jonckheere N., Vincent A., Perrais M., Ducourouble M.P., Male A.K., Aubert J.P., Pigny P., Carraway K.L., Freund J.N., Renes I.B., Van Seuningen I. The human mucin MUC4 is transcriptionally regulated by caudal-related homeobox, hepatocyte nuclear factors, forkhead box A, and GATA endodermal transcription factors in epithelial cancer cells. J. Biol. Chem. 2007, 282:22638-22650.
9. Vandenhaute B., Buisine M.P., Debailleul V., Clement B., Moniaux N., Dieu M.C., Degand P., Porchet N., Aubert J.P. Mucin gene expression in biliary epithelial cells. J. Hepatol. 1997, 27:1057-1066.
10. Sasaki M., Nakanuma Y., Kim Y.S. Expression of apomucins in the intrahepatic biliary tree in hepatolithiasis differs from that in normal liver and extrahepatic biliary obstruction. Hepatology 1998, 27:54-61.
11. Baeckstrom D., Karlsson N., Hansson G.C. Purification and characterization of sialyl-Le(a)-carrying mucins of human bile; evidence for the presence of MUC1 and MUC3 apoproteins. J. Biol. Chem. 1994, 269:14430-14437.
12. Keates A.C., Nunes D.P., Afdhal N.H., Troxler R.F., Offner G.D. Molecular cloning of a major human gall bladder mucin: complete C-terminal sequence and genomic organization of MUC5B. Biochem. J. 1997, 324(Pt 1):295-303.
13. Matull W.R., Andreola F., Loh A., Adiguzel Z., Deheragoda M., Qureshi U., Batra S.K., Swallow D.M., Pereira S.P., MUC4, MUC5AC are highly specific tumour-associated mucins in biliary tract cancer Br. J. Cancer 2008, 98:1675-1681.
14. Sasaki M., Nakanuma Y., Ho S.B., Kim Y.S. Increased MUC6 apomucin expression is a characteristic of reactive biliary epithelium in chronic viral hepatitis. J. Pathol. 1998, 185:191-198.
15. Sasaki M., Nakanuma Y., Kim Y.S. Characterization of apomucin expression in intrahepatic cholangiocarcinomas and their precursor lesions: an immunohistochemical study. Hepatology 1996, 24:1074-1078.
16. Aishima S., Kuroda Y., Nishihara Y., Taguchi K., Taketomi A., Maehara Y., Tsuneyoshi M. Gastric mucin phenotype defines tumour progression and prognosis of intrahepatic cholangiocarcinoma: gastric foveolar type is associated with aggressive tumour behaviour. Histopathology 2006, 49:35-44.
17. Sasaki M., Nakanuma Y., Ho S.B., Kim Y.S. Cholangiocarcinomas arising in cirrhosis and combined hepatocellular-cholangiocellular carcinomas share apomucin profiles. Am. J. Clin. Pathol. 1998, 109:302-308.
18. Higashi M., Yonezawa S., Ho J.J., Tanaka S., Irimura T., Kim Y.S., Sato E. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma. Hepatology 1999, 30:1347-1355.
19. Shibahara H., Tamada S., Higashi M., Goto M., Batra S.K., Hollingsworth M.A., Imai K., Yonezawa S. MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type. Hepatology 2004, 39:220-229.
20. Taylor K.L., Mall A.S., Barnard R.A., Ho S.B., Cruse J.P. Immunohistochemical detection of gastric mucin in normal and disease states. Oncol. Res. 1998, 10:465-473.
21. Ho S.B., Shekels L.L., Toribara N.W., Gipson I.K., Kim Y.S., Purdum P.P., Cherwitz D.L Altered mucin core peptide expression in acute and chronic cholecystitis. Dig. Dis. Sci. 2000, 45:1061-1071.
22. Toribara N.W., Roberton A.M., Ho S.B., Kuo W.L., Gum E., Hicks J.W., Gum J.R., Byrd J.C., Siddiki B., Kim Y.S. Human gastric mucin. Identification of a unique species by expression cloning. J. Biol. Chem. 1993, 268:5879-5885.
23. Gendler S.J., Spicer A.P., Lalani E.N., Duhig T., Peat N., Burchell J., Pemberton L., Boshell M., Taylor-Papadimitriou J. Structure and biology of a carcinoma-associated mucin, MUC1. Am. Rev. Respir. Dis. 1991, 144:S42-S47.
24. Ceriani R.L., Chan C.M., Baratta F.S., Ozzello L., DeRosa C.M., Habif D.V. Levels of expression of breast epithelial mucin detected by monoclonal antibody BrE-3 in breast-cancer prognosis. Int. J. Cancer 1992, 51:343-354.
25. Barratt-Boyes S.M. Making the most of mucin: a novel target for tumor immunotherapy. Cancer Immunol. Immunother. 1996, 43:142-151.
26. Ragupathi G. Carbohydrate antigens as targets for active specific immunotherapy. Cancer Immunol. Immunother. 1996, 43:152-157.
27. Yonezawa S., Sato E. Expression of mucin antigens in human cancers and its relationship with malignancy potential. Pathol. Int. 1997, 47:813-830.